Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.verified

TERN

Price:

$8.24

Market Cap:

$532.94M

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase Ib clinical trial for the treatment of NASH. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and TERN-601, a smal...[Read more]

Industry

Biotechnology

IPO Date

2021-02-05

Stock Exchange

NASDAQ

Ticker

TERN

The Current Ratio as of June 2024 (TTM) for Terns Pharmaceuticals, Inc. (TERN) is 27.85

According to Terns Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 27.85. This represents a change of 19.97% compared to the average of 23.22 of the last 4 quarters.

Terns Pharmaceuticals, Inc. (TERN) Historical Current Ratio (quarterly & annually)

How has TERN Current Ratio performed in the past?

The mean historical Current Ratio of Terns Pharmaceuticals, Inc. over the last ten years is 21.04. The current 27.85 Current Ratio has changed 13.14% with respect to the historical average. Over the past ten years (40 quarters), TERN's Current Ratio was at its highest in in the December 2022 quarter at 33.68. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

21.04

Median

23.43

Minimum

3.98

Maximum

37.25

Terns Pharmaceuticals, Inc. (TERN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Terns Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 514.71%

Maximum Annual Current Ratio = 37.25

Minimum Annual Increase = -87.95%

Minimum Annual Current Ratio = 3.98

Quarterly (TTM)
Annual
YearCurrent RatioChange
202322.39-33.52%
202233.6837.59%
202124.48514.71%
20203.98-11.31%
20194.49-87.95%

Terns Pharmaceuticals, Inc. (TERN) Average Current Ratio

How has TERN Current Ratio performed in the past?

The current Current Ratio of Terns Pharmaceuticals, Inc. (TERN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

26.85

5-year avg

17.80

10-year avg

21.04

Terns Pharmaceuticals, Inc. (TERN) Current Ratio vs. Peers

How is TERN’s Current Ratio compared to its peers?

Terns Pharmaceuticals, Inc.’s Current Ratio is greater than Amylyx Pharmaceuticals, Inc. (4.48), less than Acumen Pharmaceuticals, Inc. (30.20), greater than Inozyme Pharma, Inc. (14.05), greater than X4 Pharmaceuticals, Inc. (3.71), greater than Mereo BioPharma Group plc (4.86), greater than PDS Biotechnology Corporation (4.56), greater than HOOKIPA Pharma Inc. (4.50), greater than Day One Biopharmaceuticals, Inc. (10.93), greater than Eledon Pharmaceuticals, Inc. (11.30),

Build a custom stock screener for Terns Pharmaceuticals, Inc. (TERN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Terns Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Terns Pharmaceuticals, Inc. (TERN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Terns Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Terns Pharmaceuticals, Inc.'s Current Ratio?

How is the Current Ratio calculated for Terns Pharmaceuticals, Inc. (TERN)?

What is the highest Current Ratio for Terns Pharmaceuticals, Inc. (TERN)?

What is the 3-year average Current Ratio for Terns Pharmaceuticals, Inc. (TERN)?

What is the 5-year average Current Ratio for Terns Pharmaceuticals, Inc. (TERN)?

How does the current Current Ratio for Terns Pharmaceuticals, Inc. (TERN) compare to its historical average?